LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & ...
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its phase I CDMO growth strategy. The …